Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients

European Respiratory Journal

Volumn 23, Issue 6, 2004, Pages 851-856

  De Boeck, K ^a   Malfroot, A ^b   Van Schil, L ^c   Lebecque, P ^d   Knoop, C ^e   Govan, J R W ^g   Doherty, C ^g   Laevens, S ^f   Vandamme, P ^f   Ursi, J P ^c   Desager, K ^h   Ieven, G ^h   Mertens, A ⁱ   Dab, I ^b   Lauwers, S ^b   Gigi, J ^d   Struelens, M ^e   Franckx, H ^j   De Baets, F ^k   Vandaele, S ^k   Verschraegen, G ^k   Proesmans, M ^a   Van Eldere, J ^a   Lebrun, F ^l   Pauquay, F ^l   Bodart, E ^m   Glupczynski, Y ^m   Sevens, C ⁿ   more..

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c Sint Vincentiusziekenhuis   (Belgium)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e ERASME HOSPITAL   (Belgium)

^f GHENT UNIVERSITY   (Belgium)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h ANTWERP UNIVERSITY HOSPITAL   (Belgium)

ⁱ MIDDELHEIM HOSPITAL   (Belgium)

^j Zeepreventorium   (Belgium)

^k GHENT UNIVERSITY HOSPITAL   (Belgium)

^l Clinique de l'Esperance   (Belgium)

^m UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

ⁿ VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

more..

Author keywords

Burkholderia cepacia complex; Cystic fibrosis; Epidemiology; Lung infection; Microbiology

Indexed keywords

GENOMIC DNA; RECA PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BELGIUM; BURKHOLDERIA CEPACIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS INFECTION; CULTURE MEDIUM; CYSTIC FIBROSIS; DEATH; DNA RESTRICTION; FEMALE; HEALTH CARE FACILITY; HUMAN; LUNG FUNCTION; LUNG INFECTION; MALE; MORBIDITY; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPUTUM ANALYSIS; STRAIN DIFFERENCE;

EID: 3042602206     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00118804     Document Type: Article

References (33)

1. Fitzsimmons SC. Cystic Fibrosis Foundation Patient Data Registry Annual Data Report 1996, Maryland, Bethesda, USA.
2. Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104: 206-210.
3. Tablan OC, Chorba TL, Schidlow DV, et al. Pseudomonas cepacia colonisation in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985; 107: 382-387.
4. Tablan OC, Carson LA, Cusick LB, Bland LA, Martone WJ, Jarvis WR. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from stimulated sputum specimens of patients with cystic fibrosis. J Clin Microbiol 1987; 25: 485-487.
5. LiPuma JJ. Burkholderia cepacia: management issues and new insights. Clin Chest Med 1998; 19: 473-486.
6. Henry DA, Campbell M, McGimpsey C, et al. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1999; 37: 1004-1007.
7. Vandamme P, Holmes B, Vancanneyt M, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 1997; 47: 1188-1200.
8. Frangolias DD, Mahenthiralingam E, Rae S, et al. Burkholderia cepacia in cystic fibrosis. Variable disease course. Am J Respir Crit Care Med 1999; 160: 1572-1577.
9. LiPuma JJ, Spilker T, Gill LH, Campbell III PW, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001; 164: 92-96.
10. Revets H, Vandamme P, Van Zeebroeck A, et al. Burkholderia (Pseudomonas) cepacia and cystic fibrosis; the epidemiology in Belgium. Acta Clin Belg 1996; 51: 222-230.
11. Coenye T, Falsen E, Hoste B, et al. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov., and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol 2000; 50: 887-899.
12. Coeyne T, LiPuma JJ, Henry D, et al. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Int J Syst Evol Microbiol 2001; 51: 271-279.
13. Coeyne T, Mahenthiralingam E, Henry D, et al. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol 2001; 51: 1481-1490.
14. Coenye T, Vandamme P, Govan JRW, LiPuma JJ. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol 2001; 39: 3427-3436.
15. Coenye T, Goris J, Spilker T, Vandamme P, LiPuma JJ. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol 2002; 40: 2062-2069.
16. Mahenthiralingam E, Bischof J, Byrne SK, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000; 38: 3165-3173.
17. Butler SL, Doherty CJ, Hughes JE, Nelson JW, Govan JRW. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol 1995; 33: 1001-1004.
18. Sajjan US, Sun L, Goldstein R, Forstner JF. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 1995; 177: 1030-1038.
19. Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic strains of Burkholderia cepacia recovered from patients with cystic fibrosis. J Clin Microbiol 1997; 38: 910-913.
20. www.genet.sickkids.on.ca/cftr. Date last updated: October 2 2003. Date last accessed: March 24 2004.
21. Döring G, Conway SP, Heijerman HG, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000; 16: 749-767.
22. Hernandez M, Castellet J, Narval JL, et al. Curvas y tablas de Crecimiento [Growth charts and tables]. Fundación F Obregozo, Bilbao. Ed Garsi, Madrid, 1988; pp. 1-26.
23. American Thoracic Society. Standardization of Spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-1136.
24. Quanjer PH, Stocks J, Polgar G, Wise M, Karlberg J, Borsboom G. Compilation of reference values for lung function measurements in children. Eur Respir J 1989; 2: Suppl. 4, 184s-261s.
25. Coenye T, Spilker T, Martin A, LiPuma JJ. Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol 2002; 40: 3300-3307.
26. Speert D. Understanding Burkholderia cepacia: epidemiology, genomovars, and virulence. Infect Med 2001; 18: 49-56.
27. Chen JS, Witzmann KA, Spilker T, Fink RJ, Lipuma JJ. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 2001; 139: 643-649.
28. Agodi A, Mahenthiralingan E, Barchitta M, Giannino V, Sciacca A, Stefani S. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol 2001; 39: 2891-2896.
29. Clode FE, Kaufmann ME, Malnick H, Pitt TL. Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in United Kingdom. J Clin Microbiol 2000; 38: 1763-1766.
30. Holmes A, Govan J, Goldstein R. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis 1998; 4: 221-227.
31. Fiore A, Laevens S, Bevivino A, et al. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy. Environ Microbiol 2001; 3: 137-143.
32. Taylor RF, Gaya H, Hodson ME. Pseudomonas cepacia: pulmonary infection in patients with cystic fibrosis. Respir Med 1993; 87: 187-192.
33. Cimolai N, Trombley C, Davidson AG, Wong LT. Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis. J Clin Pathol 1995; 48: 488-490.